Codexis Stock

Codexis EBIT

The EBIT of Codexis (CDXS) as of Jun 14, 2026 is -58.35 T USD.In the previous year, EBIT was -54.8 T USD — a change of 6.48% (lower).

EBIT

-58.35 TUSD

YoY

6.48%

Last updated:

In 2026, Codexis's EBIT was -58.35 T USD, a 6.48% increase from the -54.8 T USD EBIT recorded in the previous year.

The Codexis EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2005
-11.2 base
Jan 1, 2006
-18.8 base
Jan 1, 2007
-38.3 base
Jan 1, 2008
-44 base
Jan 1, 2009
-18.4 base
Jan 1, 2010
-7.1 base
Jan 1, 2011
-15.9 base
Jan 1, 2012
-27.5 base
Jan 1, 2013
-40.3 base
Jan 1, 2014
-19.1 base
Jan 1, 2015
-7.8 base
Jan 1, 2016
-8.6 base
Jan 1, 2017
-23 base
Jan 1, 2018
-11.3 base
Jan 1, 2019
-12.5 base
YEAREBIT (M USD)
2031 est -
2030 est 57.11
2029 est 27.61
2028 est 14.67
2027 est -6.54
2026 est -38.89
2025 est -56.62
2024 -58.35
2023 -54.8
2022 -31.7
2021 -22.7
2020 -23.9
2019 -12.5
2018 -11.3
2017 -23
2016 -8.6
2015 -7.8
2014 -19.1
2013 -40.3
2012 -27.5
2011 -15.9
2010 -7.1
2009 -18.4
2008 -44
2007 -38.3
2006 -18.8
2005 -11.2
Access this data via the Eulerpool API

Codexis Revenue

Codexis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
11.8 M USD
-11.2 M USD
-11.6 M USD
Jan 1, 2006
12.1 M USD
-18.8 M USD
-18.7 M USD
Jan 1, 2007
25.3 M USD
-38.3 M USD
-39 M USD
Jan 1, 2008
50.5 M USD
-44 M USD
-45.1 M USD
Jan 1, 2009
82.9 M USD
-18.4 M USD
-20.3 M USD
Jan 1, 2010
107.1 M USD
-7.1 M USD
-8.5 M USD
Jan 1, 2011
123.9 M USD
-15.9 M USD
-16.6 M USD
Jan 1, 2012
88.3 M USD
-27.5 M USD
-30.9 M USD
Jan 1, 2013
31.9 M USD
-40.3 M USD
-41.3 M USD
Jan 1, 2014
35.3 M USD
-19.1 M USD
-19.1 M USD
Jan 1, 2015
41.8 M USD
-7.8 M USD
-7.6 M USD
Jan 1, 2016
48.8 M USD
-8.6 M USD
-8.6 M USD
Jan 1, 2017
50 M USD
-23 M USD
-23 M USD
Jan 1, 2018
60.6 M USD
-11.3 M USD
-10.9 M USD
Jan 1, 2019
68.5 M USD
-12.5 M USD
-11.9 M USD

Codexis Margins

Codexis stock margins

The Codexis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Codexis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Codexis.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
81.36 %
-94.92 %
-98.31 %
Jan 1, 2006
85.12 %
-155.37 %
-154.55 %
Jan 1, 2007
67.19 %
-151.38 %
-154.15 %
Jan 1, 2008
73.86 %
-87.13 %
-89.31 %
Jan 1, 2009
79.86 %
-22.2 %
-24.49 %
Jan 1, 2010
73.86 %
-6.63 %
-7.94 %
Jan 1, 2011
66.26 %
-12.83 %
-13.4 %
Jan 1, 2012
65.35 %
-31.14 %
-34.99 %
Jan 1, 2013
54.55 %
-126.33 %
-129.47 %
Jan 1, 2014
72.52 %
-54.11 %
-54.11 %
Jan 1, 2015
84.21 %
-18.66 %
-18.18 %
Jan 1, 2016
80.12 %
-17.62 %
-17.62 %
Jan 1, 2017
71.4 %
-46 %
-46 %
Jan 1, 2018
79.21 %
-18.65 %
-17.99 %
Jan 1, 2019
77.08 %
-18.25 %
-17.37 %

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Codexis's EBIT

Codexis's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Codexis's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Codexis's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Codexis’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Codexis stock

EBIT of Codexis amounted to -54.8 T USD -58.35 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Codexis

All Key Metrics — Codexis